Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 3
2012 3
2013 4
2014 5
2015 3
2016 4
2017 8
2018 13
2019 12
2020 21
2021 23
2022 17
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean qingyang shi[Author] (64 results)?
Exosomes based strategies for brain drug delivery.
Rehman FU, Liu Y, Zheng M, Shi B. Rehman FU, et al. Among authors: shi b. Biomaterials. 2023 Feb;293:121949. doi: 10.1016/j.biomaterials.2022.121949. Epub 2022 Dec 8. Biomaterials. 2023. PMID: 36525706 Review.
Integrated proteogenomic characterization of glioblastoma evolution.
Kim KH, Migliozzi S, Koo H, Hong JH, Park SM, Kim S, Kwon HJ, Ha S, Garofano L, Oh YT, D'Angelo F, Kim CI, Kim S, Lee JY, Kim J, Hong J, Jang EH, Mathon B, Di Stefano AL, Bielle F, Laurenge A, Nesvizhskii AI, Hur EM, Yin J, Shi B, Kim Y, Moon KS, Kwon JT, Lee SH, Lee SH, Gwak HS, Lasorella A, Yoo H, Sanson M, Sa JK, Park CK, Nam DH, Iavarone A, Park JB. Kim KH, et al. Among authors: shi b. Cancer Cell. 2024 Mar 11;42(3):358-377.e8. doi: 10.1016/j.ccell.2023.12.015. Epub 2024 Jan 11. Cancer Cell. 2024. PMID: 38215747
IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis.
Lin W, Niu R, Park SM, Zou Y, Kim SS, Xia X, Xing S, Yang Q, Sun X, Yuan Z, Zhou S, Zhang D, Kwon HJ, Park S, Il Kim C, Koo H, Liu Y, Wu H, Zheng M, Yoo H, Shi B, Park JB, Yin J. Lin W, et al. Among authors: shi b. Nat Commun. 2023 Mar 22;14(1):1578. doi: 10.1038/s41467-023-37306-1. Nat Commun. 2023. PMID: 36949068 Free PMC article.
Stimuli-responsive prodrug-based cancer nanomedicine.
Xie A, Hanif S, Ouyang J, Tang Z, Kong N, Kim NY, Qi B, Patel D, Shi B, Tao W. Xie A, et al. Among authors: shi b. EBioMedicine. 2020 Jun;56:102821. doi: 10.1016/j.ebiom.2020.102821. Epub 2020 Jun 7. EBioMedicine. 2020. PMID: 32505922 Free PMC article. Review.
Nanomedicine-based immunotherapy for central nervous system disorders.
Hanif S, Muhammad P, Chesworth R, Rehman FU, Qian RJ, Zheng M, Shi BY. Hanif S, et al. Acta Pharmacol Sin. 2020 Jul;41(7):936-953. doi: 10.1038/s41401-020-0429-z. Epub 2020 May 28. Acta Pharmacol Sin. 2020. PMID: 32467570 Free PMC article. Review.
119 results